天堂网亚洲,天天操天天搞,91视频高清,菠萝蜜视频在线观看入口,美女视频性感美女视频,95丝袜美女视频国产,超高清美女视频图片
Allikang Pharmaceutical Co., LTD
Firmenname:
Allikang Pharmaceutical Co., LTD
Telefon:
0573-87393005
E-Mail:
Sales@alicornpharma.com
Nationalit?t:
China
URL:
www.alicornpharma.com
Produkte insgesamt:
57
1
Produktkatalog
Ritlecitinib Intermediates
1207947-49-6
C14H20N2O2
Allisartan Isoproxil
947331-05-7
C27H29ClN6O5
Imrecoxib
395683-14-4
C21H23NO3S
Carbamic acid, N-[5-[(4-methylphenyl)sulfonyl]-5H-pyrrolo[2,3-b]pyrazin-2-yl]-, ethyl ester
1869118-24-0
C16H16N4O4S
Pimavanserin Intermediates
1837794-51-0
C13H20ClFN2
Ritlecitinib Intermediates
2922238-87-5
C13H20N2.ClH
(2-Butyl-5-nitro-3-benzofuranyl)[4-[3-(dibutylamino)propoxy]phenyl]methanone
141645-23-0
C30H40N2O5
Etrasimod Intermediates
957208-65-0
C13H14ClF3
4-(4-Cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1,6-naphthyridine-3-carboxamide
1050477-27-4
C21H22N4O3
N-[5-[(4-Methylphenyl)sulfonyl]-5H-pyrrolo[2,3-b]pyrazin-2-yl]carbamic acid 1,1-dimethylethyl ester
1201187-44-1
C18H20N4O4S
4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1,6-naphthyridine-3-carboxylic acid
1050477-45-6
C21H21N3O4
3-Pyridazinecarboxylic acid, 4,6-dichloro-, lithium salt, hydrate (1:1:1)
2245111-15-1
C5H5Cl2LiN2O3
Azilsartan
147403-03-0
C25H20N4O5
Ritlecitinib Tosylate
2192215-81-7
C22H27N5O4S
6-CHLORO-3-(1-METHYLETHYL)-2,4-(1H,3H)-PYRIMIDINEDIONE
887581-47-7
C7H9ClN2O2
2,2,14,14-tetramethyl-8-oxopentadecanedioic acid
413624-71-2
C19H34O5
Bempedoic Acid Intermediates
123469-92-1
C11H21BrO2
ritlecitinib
1792180-81-4
C15H19N5O
Ritlecitinib Intermediates
1227917-63-6
C11H22N2O2
Mavacamten
1642288-47-8
C15H19N3O2
Heptanoic acid, 7-chloro-2,2-dimethyl-, ethyl ester
2570179-39-2
C11H21ClO2
Ritlecitinib Intermediates
2295746-50-6
C13H20N2
N-methyl-N-((3R,4R)-4-methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine
477600-74-1
C13H19N5
Upadacitinib
2050057-56-0
C17H21F3N6O2
Unii-na83F1sjsr
706782-28-7
C29H40FN3O8
Azilsartan Medoxomil
863031-21-4
C30H24N4O8
7,8-difluoro-6,11-dihydro-Dibenzo[b,e]thiepin-11-ol
1985607-83-7
C14H10F2OS
Etrasimod Arginine
1206123-97-8
C32H40F3N5O5
Avatrombopag maleate
677007-74-8
C33H38Cl2N6O7S2
2-cyanoethyl 4-(4-cyano-2-methoxyphenyl)-2,8-dimethyl-5-oxo-1,4,5,6-tetrahydro-1,6-naphthyridine-3-carboxylate
1050477-43-4
C22H20N4O4
N-((3R,6S)-6-methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine
2042650-70-2
C12H17N5
Butylphthalide
3-Butylphthalid
6066-49-5
C12H14O2
(Z)-2-cyanoethyl 2-(4-cyano-2-methoxybenzylidene)-3-oxobutanoate
1050477-39-8
C16H14N2O4
Upadacitinib
1310726-60-3
C17H19F3N6O
Lobeglitazonesulfate
763108-62-9
C24H26N4O9S2
Tofacitinib Intermediates
477600-73-0
C20H25N5
Ritlecitinib Intermediates
1207853-23-3
C14H21ClN2O2
Baloxavir Marboxil
1985606-14-1
C27H23F2N3O7S
DRONEDARONE HYDROCHLORIDE
141625-93-6
C31H44N2O5S.ClH
Bicyclol
118159-48-1
C19H18O9
Finerenone
1050477-31-0
C21H22N4O3
BempedoicAcid
738606-46-7
C19H36O5
2-cyanoethyl 4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1,6-naphthyridine-3-carboxylate
1050477-44-5
C24H24N4O4
Etrasimod Intermediates
1206124-34-6
C28H30F3NO3
Deucravacitinib
1609392-27-9
C20H22N8O3
Bicyclol Intermediates
105868-34-6
C18H14O10
Bicyclol Intermediates
211996-66-6
C19H16O10
ABT-494 intermediate
1428243-24-6
C15H19NO4
Avatrombopag Impurity 22
570403-14-4
C31H38Cl2N6O3S2
Iguratimod
123663-49-0
C17H14N2O6S
Tofacitinib Citrate
540737-29-9
C16H20N6O.C6H8O7
Azilsartan kaMedoxoMil
863031-24-7
C30H25KN4O8
(3R,4S)-3-(2-Bromoacetyl)-4-ethyl-1-pyrrolidinecarboxylic acid phenylmethyl ester
1428243-26-8
C16H20BrNO3
7,8-difluorodibenzo[b,e]thiepin-11(6H)-one
2136287-66-4
C14H8F2OS
Etrasimod Intermediates
1206124-13-1
C15H17NO3
(12aR)-3,4,12,12a-Tetrahydro-7-(phenylmethoxy)- 1H-[1,4]oxazino[3,4-c]pyrido[2,1-f][1,2,4]triazine-6,8-dione
1985607-70-2
C17H17N3O4
Betahistine mesylate
54856-23-4
C8H12N2.2CH4O3S
1
Copyright 2019 ? ChemicalBook. All rights reserved